2-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine, 97%, 50mg

2-Chloro-3-nitro-5-(trifluoromethyl)benzamide, 98%, 5g

9,10-Phenanthrenequinone>99.0%(GC)5g

2-Pyrrolidin-1-ylquinolin-8-ol, 95.0%, 1g

(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95%, 1g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 25mL, >=99%, for peptide synthesis

1,3-Di(1H-imidazol-1-yl)benzene, 97%, 5g

3-Methoxy-4-nitrobenzoic acid, 98.0%, 500g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95%, 10g

2-[Bis[2-(1-methylethyl)phenyl]phosphino]-N-[(9R)-6?-methoxycinchonan-9-yl]benzamide, 100mg

Sample reservoir Visco, 650 ml, PTFE, FEP, 1 piece

2-(Pyridin-2-yloxy)ethanamine, 95.0%, 5g

1-(4-Methylpyridin-2-yl)ethanone, 97.0%, 1g